Rebecca Taub Insider Trading $CAQ VIA Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Rebecca Taub.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Rebecca Taub. Rebecca Taub is SVP, Research & Development in VIA Pharmaceuticals, Inc. ($CAQ) and Chief Medical Officer, EVP R&D in SYNTA PHARMACEUTICALS CORP ($SNTA) and Pres., R&D, and CMO in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and President of R&D in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and See Remarks in MADRIGAL PHARMACEUTICALS, INC. ($SNTA).

Rebecca Taub in VIA Pharmaceuticals, Inc.

Trading Symbol: CAQ
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rebecca Taub: SVP, Research & Development
Holdings: 157,500 shares
Latest Transaction: Dec 19 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Rebecca Taub in VIA Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, SNTA, CAQ

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 19 2008CAQVIA Pharmaceutical ...Taub RebeccaSVP, Research & Dev ...GrantA0.00125,0000157,50032.5 K to 157.5 K (+384.62 %)
Dec 19 2008CAQVIA Pharmaceutical ...Taub RebeccaSVP, Research & Dev ...BuyP0.3032,5009,75032,5000 to 32.5 K
Jan 16 2008CAQVIA Pharmaceutical ...Taub RebeccaSVP, Research & Dev ...Option ExerciseA2.90235,000681,500235,000

Page:   1